Pierre Olivier Gaudreau

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results”.

ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

Nature Medicine(2023)10.1038/s41591-023-02598-9

N/A

3.7DataRank · unranked

151 citations

Cheryl Ho, Garth Nicholas, Rosalyn A. Juergens, Adrian G. Sacher, Andrea S. Fung +15 more

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf -mutated melanoma

OncoImmunology(2021)10.1080/2162402x.2021.1992880

N/A

0DataRank · unranked

12 citations

Robert Szczepaniak‐Sloane, Russell G. Witt, Alexandre Reuben, Pierre Olivier Gaudreau, Miles C. Andrews +27 more